개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objectives: Puriton<SUP>®</SUP> is the electrolyte enriched water consisting of 31 essential minerals from biotite, kaolinite, montmorillonite, serpentine, and clinochlore, and vermiculite. It has been reported to be bactericidal and virucidal. However, the protective effect of Puriton<SUP>®</SUP> against acute pancreatitis (AP) has not yet been studied. Therefore, we aimed to evaluate the protective effect of Puriton<SUP>®</SUP> against cerulein-induced AP.
Methods: AP was induced by intraperitoneal injections of cerulein (50 μg/kg) hourly for 6 times. Puriton® (100, 300, 500, or 700 μL) was administered orally 1 hour before the first cerulein injection. Mice were sacrificed 6 hours after the last cerulein injection. Pancreas, lung, and serum samples were quickly collected for further analysis.
Results: Administration of Puriton<SUP>®</SUP> did not reduce the ratio of pancreas weight to body weight. However, the increased serum amylase and lipase were decreased in the Puriton<SUP>®</SUP> administration group, and histological damage to pancreas and lung tissue was suppressed in the Puriton<SUP>®</SUP> 100 and 300 μL administration groups, but not in the Puriton® 500 and 700 μL administration groups. Additionally, among pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, the mRNA level of only IL-6 was decreased by Puriton<SUP>®</SUP> administration.
Conclusion: In summary, we showed that the administration of Puriton<SUP>®</SUP> improved the severity of cerulein-induced AP, suggesting the possibility of being an effective drug for AP.
Methods: AP was induced by intraperitoneal injections of cerulein (50 μg/kg) hourly for 6 times. Puriton® (100, 300, 500, or 700 μL) was administered orally 1 hour before the first cerulein injection. Mice were sacrificed 6 hours after the last cerulein injection. Pancreas, lung, and serum samples were quickly collected for further analysis.
Results: Administration of Puriton<SUP>®</SUP> did not reduce the ratio of pancreas weight to body weight. However, the increased serum amylase and lipase were decreased in the Puriton<SUP>®</SUP> administration group, and histological damage to pancreas and lung tissue was suppressed in the Puriton<SUP>®</SUP> 100 and 300 μL administration groups, but not in the Puriton® 500 and 700 μL administration groups. Additionally, among pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, the mRNA level of only IL-6 was decreased by Puriton<SUP>®</SUP> administration.
Conclusion: In summary, we showed that the administration of Puriton<SUP>®</SUP> improved the severity of cerulein-induced AP, suggesting the possibility of being an effective drug for AP.
목차
서론
실험 방법
결과
고찰
결론
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Differentiation of Type 2 Autoimmune Pancreatitis Presenting as Clinical Acute Pancreatitis
Gut and Liver
2019 .01
-
고중성지방혈증에 의한 급성 췌장염
대한췌담도학회지
2017 .01
-
Risk of Pancreatic Cancer After Acute Pancreatitis: A Retrospective Analysis of the Korean National Sample Cohort
Journal of Korean Medical Science
2024 .01
-
Erratum: Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A Single-Center Experience
Gut and Liver
2019 .01
-
Current Diagnosis and Treatment of Acute Pancreatitis in Korea: A Nationwide Survey
Gut and Liver
2024 .09
-
An unusual presentation of COVID-19: Acute pancreatitis
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .11
-
약물 유발 급성 췌장염
대한췌담도학회지
2017 .01
-
고중성지방혈증에 의한 급성 췌장염 환자에 대한 임상적 접근
대한내과학회지
2020 .12
-
급성 췌장염의 중증도 예측
대한췌담도학회지
2021 .01
-
Revised Clinical Practice Guidelines of the Korean Pancreatobiliary Association for Acute Pancreatitis
Gut and Liver
2023 .01
-
Acute pancreatitis disease in the patient with COVID-19 infection: A systematic review
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
IL-8 gene polymorphism in acute biliary and non biliary pancreatitis : probable cause of high level parameters?
Annals of Hepato-Biliary-Pancreatic Surgery
2017 .02
-
Hypertriglyceridemia-induced acute pancreatitis in pregnancy causing maternal death
Obstetrics & Gynecology Science
2016 .01
-
Pancreatic cancer surgery in patients with acute pancreatitis: Peri operative outcomes
대한임상종양학회 학술대회지
2021 .06
-
Computed Tomography Assessment of Severity of Acute Pancreatitis in Bangladeshi Children
Pediatric Gastroenterology, Hepatology & Nutrition
2024 .05
-
Are traditional scoring systems for severity stratification of acute pancreatitis sufficient?
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .05
-
Correlating two-dimensional shear wave elastography of acute pancreatitis with Spec cPL in dogs
Journal of Veterinary Science
2022 .09
-
Is aggressive intravenous fluid prescription the answer to reduce mortality in severe pancreatitis? The FLIP study: Fluid resuscitation in pancreatitis
Annals of Hepato-Biliary-Pancreatic Surgery
2023 .11
-
급성췌장염에서 애틀랜타 분류 개정안 적용과 임상경과 예측: 후향적, 다기관 연구
대한췌담도학회지
2015 .04
-
Endoscopic ultrasound-guided drainage for local complications related to pancreatitis
International Journal of Gastrointestinal Intervention
2023 .01
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-24-02-090658249